Global The Urinary Tract Infection Therapeutics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

Segmented by Drugs Availability;

Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, Other Drugs (Aminoglycoside Antibodies, Sulphonamides, Tetracycline and etc.).

Segmented by Indication;

Complicated UTI, Uncomplicated UTI, Indications (Recurring Complicated UTI, Neurogenic Bladder Infection and etc.).

Segmented by Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn131647955 Published Date: May, 2024 Updated Date: June, 2024

Introduction

Global The Urinary Tract Infection Therapeutics Market (USD Million), 2020 - 2030

*Graph shown for illustrative purpose only, the final report will have the graph with actual data and data labels
# Global Market (USD Million), 2020 - 2030
2020 74.0
2021 80.7
2022 93.8
2023 105.8
2024 122.6
2025 134.0
2026 148.1
2027 174.6
2028 196.9
2029 226.6
2030 242.1

In the year 2023, the Global The Urinary Tract Infection Therapeutics Market was valued at USD 8,791.60 million. The size of this market is expected to increase to USD 11,329.89 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 3.7%.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Drugs Availability
    2. Market Snapshot, By Indication
    3. Market Snapshot, By Region
    4. Market Opportunity Map
  4. Global The Urinary Tract Infection Therapeutics Market
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing Prevalence of Diabetes and Kidney Stones
        2. Launch of Combination Drugs
      2. Restraints
        1. Adverse Effects Associated with the Use of Medication
        2. Lack of Awareness in the Developing and Underdeveloped Countries
      3. Opportunities
    2. Regulatory Scenario
    3. Reimbursement Scenario
    4. Mergers & Acquisitions, Collaborations & Partnerships, Agreements
    5. Pipeline Analysis/Technological Advancements
    6. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    7. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bragaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Industry Rivalry
  5. Market Segmentation
    1. Global The Urinary Tract Infection Therapeutics Market, By Drugs Availability, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Penicillin and Combinations
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Quinolones
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Cephalosporin
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        4. Azoles and Amphotericin B
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        5. Nitrofurans
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        6. Other Drugs (Aminoglycoside Antibodies, Sulphonamides, Tetracycline, etc.)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    2. Global The Urinary Tract Infection Therapeutics Market, By Indication, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Segment Trends
        1. Complicated UTI
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        2. Uncomplicated UTI
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
        3. Indications (Recurring Complicated UTI, Neurogenic Bladder Infection, etc.)
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
    3. Global The Urinary Tract Infection Therapeutics Market, By Geography, 2020 - 2030 (USD Million)
      1. Introduction
      2. Market Share Analysis, 2024 and 2030 (%)
      3. Y-o-Y Growth Analysis, 2021 - 2030
      4. Regional Trends
        1. North America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. United States
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. Canada
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        2. Europe
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. Germany
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. United Kingdom
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. France
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Italy
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            5. Spain
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            6. Rest of Europe
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        3. Asia Pacific
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. Japan
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. China
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. India
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Australia & New Zealand
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            5. South Korea
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            6. ASEAN (Association of South East Asian Countries)
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            7. Rest of Asia Pacific
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        4. Middle East & Africa
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. GCC
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. Israel
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. South Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Rest of Middle East & Africa
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
        5. Latin America
          1. Introduction
          2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
          3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            1. Brazil
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            2. Mexico
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            3. Argentina
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
            4. Rest of Latin America
              1. Introduction
              2. Market Size and Forecast, and Y-o-Y Growth, By Drugs Availability, 2020 - 2030 (USD Million)
              3. Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2030 (USD Million)
  6. Competitive Landscape
    1. Heat Map Analysis
    2. Company Profiles
      1. AstraZeneca
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      2. Bayer AG
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      3. Cipla Inc.
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
      4. GlaxoSmithKline PLC
        1. Company Overview and Product Portfolio
        2. Key Developments
        3. Financial Overview
        4. Strategies
        5. Company SWOT Analysis
  7. Analyst Views
  8. Future Outlook of the Market